Last reviewed · How we verify
Yangxinshi tablet simulants
Yangxinshi tablet is a traditional Chinese medicine formulation that supports cardiac function and improves blood circulation.
Yangxinshi tablet is a traditional Chinese medicine formulation that supports cardiac function and improves blood circulation. Used for Angina pectoris, Heart failure symptoms, Cardiac arrhythmias.
At a glance
| Generic name | Yangxinshi tablet simulants |
|---|---|
| Sponsor | Dongzhimen Hospital, Beijing |
| Drug class | Traditional Chinese medicine herbal formulation |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This herbal tablet combines multiple botanical ingredients traditionally used in Chinese medicine to enhance myocardial contractility, improve coronary blood flow, and reduce cardiac workload. It is designed to address symptoms of angina pectoris and heart failure by promoting qi and blood circulation while strengthening cardiac function.
Approved indications
- Angina pectoris
- Heart failure symptoms
- Cardiac arrhythmias
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Yangxinshi tablet simulants CI brief — competitive landscape report
- Yangxinshi tablet simulants updates RSS · CI watch RSS
- Dongzhimen Hospital, Beijing portfolio CI